Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 90

1.

The angiotensin II type 1 receptor blocker azilsartan can overwhelm the sympathetic nerve activation stimulated by coadministration of calcium channel blockers.

Fukuda M, Isobe-Sasaki Y, Sato R, Miura T, Mizuno M, Ono M, Kiyono K, Yamamoto Y, Hayano J, Ohte N.

J Renin Angiotensin Aldosterone Syst. 2019 Jan-Mar;20(1):1470320319839525. doi: 10.1177/1470320319839525.

2.

Leucine-485 deletion variant of BRAF may exhibit the severe end of the clinical spectrum of CFC syndrome.

Suzuki-Muromoto S, Miyabayashi T, Nagai K, Yamamura-Suzuki S, Anzai M, Takezawa Y, Sato R, Okubo Y, Endo W, Inui T, Togashi N, Kikuchi A, Niihori T, Aoki Y, Kure S, Haginoya K.

J Hum Genet. 2019 May;64(5):499-504. doi: 10.1038/s10038-019-0579-3. Epub 2019 Mar 6.

PMID:
30842599
3.

Corrigendum: Urinary Exosome-Derived microRNAs Reflecting the Changes in Renal Function in Cats.

Ichii O, Ohta H, Horino T, Nakamura T, Hosotani M, Mizoguchi T, Morishita K, Nakamura K, Sasaki N, Takiguchi M, Sato R, Oyamada K, Elewa YHA, Kon Y.

Front Vet Sci. 2019 Jan 28;6:2. doi: 10.3389/fvets.2019.00002. eCollection 2019.

4.

YnbB is a CdsA paralogue dedicated to biosynthesis of glycolipid MPIase involved in membrane protein integration.

Sato R, Sawasato K, Nishiyama KI.

Biochem Biophys Res Commun. 2019 Mar 19;510(4):636-642. doi: 10.1016/j.bbrc.2019.01.145. Epub 2019 Feb 8.

PMID:
30739787
5.

CdsA is involved in biosynthesis of glycolipid MPIase essential for membrane protein integration in vivo.

Sawasato K, Sato R, Nishikawa H, Iimura N, Kamemoto Y, Fujikawa K, Yamaguchi T, Kuruma Y, Tamura Y, Endo T, Ueda T, Shimamoto K, Nishiyama KI.

Sci Rep. 2019 Feb 4;9(1):1372. doi: 10.1038/s41598-018-37809-8.

6.

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients.

Saruwatari K, Sato R, Nakane S, Sakata S, Takamatsu K, Jodai T, Mito R, Horio Y, Saeki S, Tomita Y, Sakagami T.

Cancers (Basel). 2019 Jan 24;11(2). pii: E140. doi: 10.3390/cancers11020140.

7.

Laparoscopic Surgery for the Treatment of Mesenteric Phlebosclerosis.

Yoshida T, Homma S, Ohno Y, Ichikawa N, Kawamura H, Sato R, Ohta T, Imamoto T, Matsuno Y, Taketomi A.

Am Surg. 2018 Dec 1;84(12):e544-e546. No abstract available.

PMID:
30606371
8.

Splicing-Dependent Subcellular Targeting of Borna Disease Virus Nucleoprotein Isoforms.

Kojima S, Sato R, Yanai M, Komatsu Y, Horie M, Igarashi M, Tomonaga K.

J Virol. 2019 Feb 19;93(5). pii: e01621-18. doi: 10.1128/JVI.01621-18. Print 2019 Mar 1.

PMID:
30541858
9.

Urinary Exosome-Derived microRNAs Reflecting the Changes in Renal Function in Cats.

Ichii O, Ohta H, Horino T, Nakamura T, Hosotani M, Mizoguchi T, Morishita K, Nakamura K, Sasaki N, Takiguchi M, Sato R, Oyamada K, Elewa YHA, Kon Y.

Front Vet Sci. 2018 Nov 20;5:289. doi: 10.3389/fvets.2018.00289. eCollection 2018. Erratum in: Front Vet Sci. 2019 Jan 28;6:2.

10.

A novel homozygous mutation of the TFG gene in a patient with early onset spastic paraplegia and later onset sensorimotor polyneuropathy.

Miyabayashi T, Ochiai T, Suzuki N, Aoki M, Inui T, Okubo Y, Sato R, Togashi N, Takashima H, Ishiura H, Tsuji S, Koh K, Takiyama Y, Haginoya K.

J Hum Genet. 2019 Feb;64(2):171-176. doi: 10.1038/s10038-018-0538-4. Epub 2018 Nov 22.

PMID:
30467354
11.

A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti-PD-1 immune checkpoint antibody in a lung cancer patient.

Jodai T, Yoshida C, Sato R, Kakiuchi Y, Sato N, Iyama S, Kimura T, Saruwatari K, Saeki S, Ichiyasu H, Fujii K, Tomita Y.

Immun Inflamm Dis. 2019 Mar;7(1):3-6. doi: 10.1002/iid3.238. Epub 2018 Nov 21.

12.

Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients.

Akaike K, Saruwatari K, Okabayashi H, Hamada S, Jodai Y, Jodai T, Sakata S, Iyama S, Sato R, Iriki T, Tomita Y, Saeki S, Ichiyasu H, Fujii K.

Anticancer Res. 2018 Nov;38(11):6543-6550. doi: 10.21873/anticanres.13020.

PMID:
30396984
13.

[18F]fluorodeoxyglucose-positron emission tomography study of genetically confirmed patients with Dravet syndrome.

Haginoya K, Togashi N, Kaneta T, Hino-Fukuyo N, Ishitobi M, Kakisaka Y, Uematsu M, Inui T, Okubo Y, Sato R, Miyabayashi T, Arai A, Ogiwara I, Mazaki E, Yamakawa K, Iinuma K, Kure S.

Epilepsy Res. 2018 Nov;147:9-14. doi: 10.1016/j.eplepsyres.2018.08.008. Epub 2018 Aug 27.

PMID:
30176532
14.

Preparation and Antiviral Activity of Some New C3- and CS-Symmetrical Tri-Substituted Triazine Derivatives Having Benzylamine Substituents.

Mibu N, Yokomizo K, Sano M, Kawaguchi Y, Morimoto K, Shimomura S, Sato R, Hiraga N, Matsunaga A, Zhou JR, Ohata T, Aki H, Sumoto K.

Chem Pharm Bull (Tokyo). 2018;66(8):830-838. doi: 10.1248/cpb.c18-00274.

15.

Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient.

Horio Y, Takamatsu K, Tamanoi D, Sato R, Saruwatari K, Ikeda T, Nakane S, Nakajima M, Saeki S, Ichiyasu H, Fujii K, Tomita Y.

Eur J Immunol. 2018 Oct;48(10):1764-1767. doi: 10.1002/eji.201847645. Epub 2018 Jul 19.

PMID:
29981156
16.

Two Japanese cases of epileptic encephalopathy associated with an FGF12 mutation.

Takeguchi R, Haginoya K, Uchiyama Y, Fujita A, Nagura M, Takeshita E, Inui T, Okubo Y, Sato R, Miyabayashi T, Togashi N, Saito T, Nakagawa E, Sugai K, Nakashima M, Saitsu H, Matsumoto N, Sasaki M.

Brain Dev. 2018 Sep;40(8):728-732. doi: 10.1016/j.braindev.2018.04.002. Epub 2018 Apr 23.

PMID:
29699863
17.

A case of new PCDH12 gene variants presented as dyskinetic cerebral palsy with epilepsy.

Suzuki-Muromoto S, Wakusawa K, Miyabayashi T, Sato R, Okubo Y, Endo W, Inui T, Togashi N, Kato A, Oba H, Nakashima M, Saitsu H, Matsumoto N, Haginoya K.

J Hum Genet. 2018 Jun;63(6):749-753. doi: 10.1038/s10038-018-0432-0. Epub 2018 Mar 19.

PMID:
29556033
18.

A case series of favorable vessel dilatation using a nitinol scoring element-equipped helical balloon catheter (AngioSculptĀ®).

Sato R, Sato T, Shirasawa Y, Kondo C, Tadakoshi M, Fukuda M, Ohte N, Morozumi K.

J Vasc Access. 2019 May;20(1_suppl):93-96. doi: 10.1177/1129729818757978. Epub 2018 Mar 15.

PMID:
29544387
19.

Air-Stable and High-Performance Solution-Processed Organic Light-Emitting Devices Based on Hydrophobic Polymeric Ionic Liquid Carrier-Injection Layers.

Sato S, Ohisa S, Hayashi Y, Sato R, Yokoyama D, Kato T, Suzuki M, Chiba T, Pu YJ, Kido J.

Adv Mater. 2018 May;30(18):e1705915. doi: 10.1002/adma.201705915. Epub 2018 Mar 13.

PMID:
29532962
20.

Effect of Angiotensin II on Matrix Metalloproteinase-2 Secretion in Human Umbilical Vein Endothelial Cells.

Sato R, Hiraishi C, Yoshida H.

J Cardiovasc Pharmacol. 2018 Apr;71(4):233-239. doi: 10.1097/FJC.0000000000000564.

PMID:
29369845

Supplemental Content

Loading ...
Support Center